Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2012 3
2013 3
2014 2
2015 1
2016 3
2017 5
2018 6
2019 11
2020 15
2021 15
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Burgents JE, Xu L, Imai K, Quinn DI, Choueiri TK; KEYNOTE-564 Investigators. Powles T, et al. Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9. Lancet Oncol. 2022. PMID: 36055304 Free article. Clinical Trial.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
Ultra-Endurance Participation and Acute Kidney Injury: A Narrative Review.
Tidmas V, Brazier J, Bottoms L, Muniz D, Desai T, Hawkins J, Sridharan S, Farrington K. Tidmas V, et al. Among authors: muniz d. Int J Environ Res Public Health. 2022 Dec 15;19(24):16887. doi: 10.3390/ijerph192416887. Int J Environ Res Public Health. 2022. PMID: 36554767 Free PMC article. Review.
Use of Flavonoids and Cinnamates, the Main Photoprotectors with Natural Origin.
Nunes AR, Vieira ÍGP, Queiroz DB, Leal ALAB, Maia Morais S, Muniz DF, Calixto-Junior JT, Coutinho HDM. Nunes AR, et al. Among authors: muniz df. Adv Pharmacol Sci. 2018 Nov 28;2018:5341487. doi: 10.1155/2018/5341487. eCollection 2018. Adv Pharmacol Sci. 2018. PMID: 30622564 Free PMC article. Review.
NorA, Tet(K), MepA, and MsrA Efflux Pumps in Staphylococcus aureus, their Inhibitors and 1,8-Naphthyridine Sulfonamides.
de Morais Oliveira-Tintino CD, Muniz DF, Dos Santos Barbosa CR, Silva Pereira RL, Begnini IM, Rebelo RA, da Silva LE, Mireski SL, Nasato MC, Lacowicz Krautler MI, Barros Oliveira CV, Pereira PS, Rodrigues Teixeira AM, Tintino SR, de Menezes IRA, Melo Coutinho HD, da Silva TG. de Morais Oliveira-Tintino CD, et al. Among authors: muniz df. Curr Pharm Des. 2023;29(5):323-355. doi: 10.2174/1381612829666221212101501. Curr Pharm Des. 2023. PMID: 36515045 Review.
The 1,8-naphthyridines sulfonamides are NorA efflux pump inhibitors.
Oliveira-Tintino CDM, Muniz DF, Barbosa CRDS, Pereira RLS, Begnini IM, Rebelo RA, Silva LED, Mireski SL, Nasato MC, Krautler MIL, Pereira PS, Costa JGMD, Rodrigues FFG, Teixeira AMR, Ribeiro-Filho J, Tintino SR, de Menezes IRA, Coutinho HDM, Silva TGD. Oliveira-Tintino CDM, et al. Among authors: muniz df. J Glob Antimicrob Resist. 2021 Mar;24:233-240. doi: 10.1016/j.jgar.2020.11.027. Epub 2020 Dec 29. J Glob Antimicrob Resist. 2021. PMID: 33385589 Free article.
Physiological demands and motion analysis of elite foil fencing.
Bottoms L, Tarragó R, Muñiz D, Chaverri D, Irurtia A, Castizo-Olier J, Carrasco M, Rodríguez FA, Iglesias X. Bottoms L, et al. Among authors: muniz d. PLoS One. 2023 Feb 14;18(2):e0281600. doi: 10.1371/journal.pone.0281600. eCollection 2023. PLoS One. 2023. PMID: 36787335 Free PMC article.
68 results